{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:53:41Z","timestamp":1773435221636,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11060-020-03594-6","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:42:31Z","timestamp":1599738151000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-2314","authenticated-orcid":false,"given":"Milo Alexander","family":"Hollingworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios","family":"Zacharoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"3594_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/neuonc\/nov250","volume":"18","author":"SE Veldhuijzen van Zanten","year":"2016","unstructured":"Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH et al (2016) Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey. Neuro Oncol 18:582\u2013588","journal-title":"Neuro Oncol"},{"key":"3594_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2016","unstructured":"Hargrave D, Bartels U, Bouffet E (2016) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241\u2013248","journal-title":"Lancet Oncol"},{"key":"3594_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/brainsci8110200","volume":"8","author":"KF Loveson","year":"2018","unstructured":"Loveson KF, Fillmore HL (2018) Intersection of brain development and paediatric diffuse midline gliomas: potential role of microenvironment in tumour growth. Brain Sci 8:200","journal-title":"Brain Sci"},{"key":"3594_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou208.24","author":"KJ Cohen","year":"2014","unstructured":"Cohen KJ, Jones A, Raabe E, Pearl M (2014) Highly selective intra-arterial chemotherapy for the treatment of progressive diffuse intrinsic pontine gliomas (DIPG). Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nou208.24","journal-title":"Neuro Oncol"},{"key":"3594_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now078.21","author":"WGB Singleton","year":"2016","unstructured":"Singleton WGB, Barua NU, Morgan J et al (2016) NS-21: multi-catheter intermittent convection-enhanced delivery of carboplatin as a treatment for diffuse intrinsic pontine glioma (DIPG): pre-clinical rationale and early clinical experience. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/now078.21","journal-title":"Neuro Oncol"},{"issue":"8","key":"3594_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(18)30322-X","volume":"19","author":"MM Souweidane","year":"2018","unstructured":"Souweidane MM, Kramer K, Pandit-Taskar N et al (2018) Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol 19(8):1040\u20131050","journal-title":"Lancet Oncol"},{"key":"3594_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy059.158","author":"M Hollingworth","year":"2018","unstructured":"Hollingworth M, Hurter C, Wooley M, Lewis O, Gill S, Zacharoulis S (2018) DIPG-65. preliminary experience of chronic intermittent convection enhanced delivery of carboplatin and valproic acid for the treatment of diffuse intrinsic pontine glioma following radiation therapy. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noy059.158","journal-title":"Neuro Oncol"},{"key":"3594_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pbc.25266","volume":"62","author":"MW Kieran","year":"2015","unstructured":"Kieran MW (2015) Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). Pediatr Blood Cancer 62:3\u20134","journal-title":"Pediatr Blood Cancer"},{"key":"3594_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/0883073815601495","volume":"31","author":"T Hennika","year":"2016","unstructured":"Hennika T, Becher OJ (2016) Diffuse intrinsic pontine glioma: time for cautious optimism. J Child Neurol 31:1377\u20131385","journal-title":"J Child Neurol"},{"key":"3594_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not151","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/not151","journal-title":"Neuro Oncol"},{"key":"3594_CR11","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","volume":"91","author":"RH Bobo","year":"1994","unstructured":"Bobo RH, Laske DW, Akbasak A et al (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076\u20132080","journal-title":"Proc Natl Acad Sci USA"},{"key":"3594_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5214\/ans.0972.7531.200306","volume":"20","author":"G Miranpuri","year":"2013","unstructured":"Miranpuri G, Hinchman A, Wang A et al (2013) Convection enhanced delivery: a comparison of infusion characteristics in ex vivo and in vivo non-human primate brain tissue. Ann Neurosci 20:108\u2013114","journal-title":"Ann Neurosci"},{"issue":"5","key":"3594_CR13","doi-asserted-by":"publisher","first-page":"e0176855","DOI":"10.1371\/journal.pone.0176855","volume":"12","author":"CL Killick-Cole","year":"2017","unstructured":"Killick-Cole CL, Singleton WGB, Bienemann AS et al (2017) Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma. PLoS ONE 12(5):e0176855","journal-title":"PLoS ONE"},{"key":"3594_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00701-013-1700-6","volume":"155","author":"NU Barua","year":"2013","unstructured":"Barua NU, Lowis SP, Woolley M, O'Sullivan S, Harrison R, Gill SS (2013) Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma. Acta Neurochir (Wien) 155:1459\u20131465","journal-title":"Acta Neurochir (Wien)"},{"key":"3594_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/10717544.2014.908248","volume":"23","author":"NU Barua","year":"2016","unstructured":"Barua NU, Hopkins K, Woolley M et al (2016) A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma. Drug Deliv 23:167\u2013173","journal-title":"Drug Deliv"},{"key":"3594_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/STROKEAHA.110.607192","volume":"42","author":"RN Ichord","year":"2011","unstructured":"Ichord RN, Bastian R, Abraham L et al (2011) Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study. Stroke 42:613\u2013617","journal-title":"Stroke"},{"key":"3594_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, de Montcel ST, Baliko L et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717\u20131720","journal-title":"Neurology"},{"key":"3594_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/dmcn.12369","volume":"56","author":"R Brandsma","year":"2014","unstructured":"Brandsma R, Spits AH, Kuiper MJ et al (2014) Ataxia rating scales are age-dependent in healthy children. Dev Med Child Neurol 56:556\u2013563","journal-title":"Dev Med Child Neurol"},{"key":"3594_CR19","first-page":"9","volume":"14","author":"DL Wong","year":"1998","unstructured":"Wong DL, Baker CM (1998) Pain in children: comparison of assessment scales. Pediatr Nurs 14:9\u201317","journal-title":"Pediatr Nurs"},{"key":"3594_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/019459988509300202","volume":"93","author":"JW House","year":"1985","unstructured":"House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146\u2013147","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3594_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00455-014-9534-9","volume":"29","author":"CL Lazarus","year":"2014","unstructured":"Lazarus CL, Husaini H, Jacobson AS et al (2014) Development of a new lingual range-of-motion assessment scale: normative data in surgically treated oral cancer patients. Dysphagia 29:489\u2013499","journal-title":"Dysphagia"},{"key":"3594_CR22","first-page":"146","volume-title":"DeJong\u2019s the neurologic examination","author":"W Campbell","year":"2005","unstructured":"Campbell W, DeJong RN (2005) Cranial nerves. In: Campbell W (ed) DeJong\u2019s the neurologic examination, 7th edn. Lipincott Williams and Wilkins, Philidelphia, pp 146\u2013161","edition":"7"},{"key":"3594_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135\u2013160","journal-title":"Stat Methods Med Res"},{"key":"3594_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","volume":"6","author":"GO Boateng","year":"2018","unstructured":"Boateng GO, Neilands TB, Frongillo EA, Melgar-Qui\u00f1onez HR, Young SL (2018) Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health 6:149","journal-title":"Front Public Health"},{"key":"3594_CR25","unstructured":"Royal College of Nursing (2017) Standards for assessing measuring and monitoring vital signs in infants, children and young people. https:\/\/www.rcn.org.uk\/-\/media\/royal-college-of-nursing\/documents\/publications\/2017\/may\/pub-005942.pdf. Accessed 30 June 2020"},{"key":"3594_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/neuonc\/nox029","volume":"19","author":"L Nayak","year":"2017","unstructured":"Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Nancy U, Lin NU et al (2017) The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol 19:625\u2013635","journal-title":"Neuro Oncol"},{"key":"3594_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov270","author":"JL Helfer","year":"2016","unstructured":"Helfer JL, Wen PY, Blakeley J, Gilbert MR, Armstrong TS (2016) Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD). Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nov270","journal-title":"Neuro Oncol"},{"key":"3594_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov267","author":"TS Armstrong","year":"2016","unstructured":"Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C (2016) Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: panel 1 report. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nov267","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03594-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T23:22:34Z","timestamp":1631143354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03594-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03594-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval for treatment on compassionate grounds was granted by the institutional ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}